Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs
Autor(a) principal: | |
---|---|
Data de Publicação: | 2007 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1590/S0100-879X2007000100005 http://hdl.handle.net/11449/224854 |
Resumo: | No fully effective treatment has been developed since the discovery of Chagas' disease by Carlos Chagas in 1909. Since drug-resistant Trypanosoma cruzi strains are occurring and the current therapy is effectiveness in the acute phase but with various adverse side effects, more studies are needed to characterize the susceptibility of T. cruzi to new drugs. Many natural and/or synthetic substances showing trypanocidal activity have been used, even though they are not likely to be turned into clinically approved drugs. Originally, drug screening was performed using natural products, with only limited knowledge of the molecular mechanism involved in the development of diseases. Trans-splicing, which is unusual RNA processing reaction and occurs in nematodes and trypanosomes, implies the processing of polycistronic transcription units into individual mRNAs; a short transcript spliced leader (SL RNA) is trans-spliced to the acceptor pre-mRNA, giving origin to the mature mRNA. In the present study, permeable cells of T. cruzi epimastigote forms (Y, BOL and NCS strains) were treated to evaluate the interference of two drugs (hydroxymethylnitrofurazone- NFOH-121 and nitrofurazone) in the trans-splicing reaction using silver-stained PAGE analysis. Both drugs induced a significant reduction in RNA processing at concentrations from 5 to 12.5 μM. These data agreed with the biological findings, since the number of parasites decreased, especially with NFOH-121, This proposed methodology allows a rapid and cost-effective screening strategy for detecting drug interference in the trans-splicing mechanis of T. cruzi. © 2007 Brazilian Journal of Medical and Biological Research. |
id |
UNSP_cd712bccfbc17b03ff1fd6a664cf1975 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/224854 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAsHydroxymethylnitrofurazonePermeable cellsRNA processingTrans-splicingTrypanocidal drugsTrypanosoma cruziNo fully effective treatment has been developed since the discovery of Chagas' disease by Carlos Chagas in 1909. Since drug-resistant Trypanosoma cruzi strains are occurring and the current therapy is effectiveness in the acute phase but with various adverse side effects, more studies are needed to characterize the susceptibility of T. cruzi to new drugs. Many natural and/or synthetic substances showing trypanocidal activity have been used, even though they are not likely to be turned into clinically approved drugs. Originally, drug screening was performed using natural products, with only limited knowledge of the molecular mechanism involved in the development of diseases. Trans-splicing, which is unusual RNA processing reaction and occurs in nematodes and trypanosomes, implies the processing of polycistronic transcription units into individual mRNAs; a short transcript spliced leader (SL RNA) is trans-spliced to the acceptor pre-mRNA, giving origin to the mature mRNA. In the present study, permeable cells of T. cruzi epimastigote forms (Y, BOL and NCS strains) were treated to evaluate the interference of two drugs (hydroxymethylnitrofurazone- NFOH-121 and nitrofurazone) in the trans-splicing reaction using silver-stained PAGE analysis. Both drugs induced a significant reduction in RNA processing at concentrations from 5 to 12.5 μM. These data agreed with the biological findings, since the number of parasites decreased, especially with NFOH-121, This proposed methodology allows a rapid and cost-effective screening strategy for detecting drug interference in the trans-splicing mechanis of T. cruzi. © 2007 Brazilian Journal of Medical and Biological Research.Departamento de Ciências Biológicas Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, Rod. Araraquara-Jaú, km 01, 14801-902 Araraquara, SPDepartamento de Fármacos e Medicamentos Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, Rod. Araraquara-Jaú, km 01, 14801-902 Araraquara, SPDepartamento de Farmácia Faculdade de Ciências Farmacêuticas Universidade de São Paulo, São Paulo, SPDepartamento de Ciências Biológicas Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, Rod. Araraquara-Jaú, km 01, 14801-902 Araraquara, SPDepartamento de Fármacos e Medicamentos Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, Rod. Araraquara-Jaú, km 01, 14801-902 Araraquara, SPUniversidade Estadual Paulista (UNESP)Universidade de São Paulo (USP)Barbosa, C. F. [UNESP]Okuda, E. S. [UNESP]Chung, M. C. [UNESP]Ferreira, E. I.Cicarelli, R. M.B. [UNESP]2022-04-28T20:14:43Z2022-04-28T20:14:43Z2007-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article33-39http://dx.doi.org/10.1590/S0100-879X2007000100005Brazilian Journal of Medical and Biological Research, v. 40, n. 1, p. 33-39, 2007.0100-879X1678-4510http://hdl.handle.net/11449/22485410.1590/S0100-879X20070001000052-s2.0-33846271829Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengBrazilian Journal of Medical and Biological Researchinfo:eu-repo/semantics/openAccess2024-06-24T13:45:50Zoai:repositorio.unesp.br:11449/224854Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T18:55:41.585321Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs |
title |
Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs |
spellingShingle |
Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs Barbosa, C. F. [UNESP] Hydroxymethylnitrofurazone Permeable cells RNA processing Trans-splicing Trypanocidal drugs Trypanosoma cruzi |
title_short |
Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs |
title_full |
Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs |
title_fullStr |
Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs |
title_full_unstemmed |
Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs |
title_sort |
Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs |
author |
Barbosa, C. F. [UNESP] |
author_facet |
Barbosa, C. F. [UNESP] Okuda, E. S. [UNESP] Chung, M. C. [UNESP] Ferreira, E. I. Cicarelli, R. M.B. [UNESP] |
author_role |
author |
author2 |
Okuda, E. S. [UNESP] Chung, M. C. [UNESP] Ferreira, E. I. Cicarelli, R. M.B. [UNESP] |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (UNESP) Universidade de São Paulo (USP) |
dc.contributor.author.fl_str_mv |
Barbosa, C. F. [UNESP] Okuda, E. S. [UNESP] Chung, M. C. [UNESP] Ferreira, E. I. Cicarelli, R. M.B. [UNESP] |
dc.subject.por.fl_str_mv |
Hydroxymethylnitrofurazone Permeable cells RNA processing Trans-splicing Trypanocidal drugs Trypanosoma cruzi |
topic |
Hydroxymethylnitrofurazone Permeable cells RNA processing Trans-splicing Trypanocidal drugs Trypanosoma cruzi |
description |
No fully effective treatment has been developed since the discovery of Chagas' disease by Carlos Chagas in 1909. Since drug-resistant Trypanosoma cruzi strains are occurring and the current therapy is effectiveness in the acute phase but with various adverse side effects, more studies are needed to characterize the susceptibility of T. cruzi to new drugs. Many natural and/or synthetic substances showing trypanocidal activity have been used, even though they are not likely to be turned into clinically approved drugs. Originally, drug screening was performed using natural products, with only limited knowledge of the molecular mechanism involved in the development of diseases. Trans-splicing, which is unusual RNA processing reaction and occurs in nematodes and trypanosomes, implies the processing of polycistronic transcription units into individual mRNAs; a short transcript spliced leader (SL RNA) is trans-spliced to the acceptor pre-mRNA, giving origin to the mature mRNA. In the present study, permeable cells of T. cruzi epimastigote forms (Y, BOL and NCS strains) were treated to evaluate the interference of two drugs (hydroxymethylnitrofurazone- NFOH-121 and nitrofurazone) in the trans-splicing reaction using silver-stained PAGE analysis. Both drugs induced a significant reduction in RNA processing at concentrations from 5 to 12.5 μM. These data agreed with the biological findings, since the number of parasites decreased, especially with NFOH-121, This proposed methodology allows a rapid and cost-effective screening strategy for detecting drug interference in the trans-splicing mechanis of T. cruzi. © 2007 Brazilian Journal of Medical and Biological Research. |
publishDate |
2007 |
dc.date.none.fl_str_mv |
2007-01-01 2022-04-28T20:14:43Z 2022-04-28T20:14:43Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S0100-879X2007000100005 Brazilian Journal of Medical and Biological Research, v. 40, n. 1, p. 33-39, 2007. 0100-879X 1678-4510 http://hdl.handle.net/11449/224854 10.1590/S0100-879X2007000100005 2-s2.0-33846271829 |
url |
http://dx.doi.org/10.1590/S0100-879X2007000100005 http://hdl.handle.net/11449/224854 |
identifier_str_mv |
Brazilian Journal of Medical and Biological Research, v. 40, n. 1, p. 33-39, 2007. 0100-879X 1678-4510 10.1590/S0100-879X2007000100005 2-s2.0-33846271829 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Brazilian Journal of Medical and Biological Research |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
33-39 |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808129000082505728 |